Rothschild Investment LLC’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.44K Buy
471
+240
+104% +$2.15K ﹤0.01% 2348
2026
Q1
$1.88K Buy
231
+67
+41% +$607 ﹤0.01% 2589
2025
Q4
$1.1K Sell
164
-126
-43% -$950 ﹤0.01% 2643
2025
Q3
$2.51K Sell
290
-40
-12% -$311 ﹤0.01% 2087
2025
Q2
$2.08K Buy
330
+100
+43% +$662 ﹤0.01% 2051
2025
Q1
$1.47K Buy
230
+85
+59% +$703 ﹤0.01% 2095
2024
Q4
$1.17K Buy
145
+15
+12% +$145 ﹤0.01% 2119
2024
Q3
$1.64K Buy
130
+80
+160% +$1.03K ﹤0.01% 1831
2024
Q2
$633 Buy
+50
New +$503 ﹤0.01% 1877

Other funds holding NVAX

Rothschild Investment LLC's NVAX Position: Q2 2026 in Review

Rothschild Investment LLC increased its Novavax (NVAX) stake by 104% in Q2 2026, buying an estimated $2.15K and bringing the position to 471 shares worth $4.44K. The position accounts for ﹤0.01% of the portfolio, ranked #2348.

Rothschild Investment LLC first reported a position in NVAX in Q2 2024 and has held it in 9 quarters since. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Rothschild Investment LLC held 471 shares of Novavax worth $4.44K as of Q2 2026.
  • Rothschild Investment LLC bought 240 Novavax shares in Q2 2026, an estimated $2.15K.
  • Novavax made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2348 holding.
  • Rothschild Investment LLC first reported a position in Novavax in Q2 2024 and has held it in 9 quarters since.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.